Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- BLRX
- Price
- 2.81
- Stock movement up
- +0.08 (2.84%)
- Company name
- BioLineRx Ltd
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 12.36M
- Ent value
- 24.72M
- Price/Sales
- 0.72
- Price/Book
- 0.63
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -74.37%
- 1 year return (CAGR)
- -24.87%
- 3 year return (CAGR)
- -50.56%
- 5 year return (CAGR)
- -54.18%
- 10 year return (CAGR)
- -40.83%
Last updated: 2026-02-20
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
BLRX does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | 2.32 |
| EV to EBITDA | 4.64 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.72 |
| Price to Book | 0.63 |
| EV to Sales | 1.43 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 4.26M |
| EPS (TTM) | -1.98 |
| FCF per share (TTM) | -3.42 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 17.25M |
| Gross profit (TTM) | 10.23M |
| Operating income (TTM) | -11.33M |
| Net income (TTM) | -7.82M |
| EPS (TTM) | -1.98 |
| EPS (1y forward) | -0.67 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 59.32% |
| Operating margin (TTM) | -65.66% |
| Profit margin (TTM) | -45.34% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 7.91M |
| Net receivables | 0.00 |
| Total current assets | 28.52M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 892.00K |
| Total assets | 39.80M |
| Accounts payable | 3.54M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 13.67M |
| Total liabilities | 20.27M |
| Shareholder's equity | 19.53M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -13.48M |
| Capital expenditures (TTM) | 6.00K |
| Free cash flow (TTM) | -13.49M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -40.05% |
| Return on Assets | -19.65% |
| Return on Invested Capital | -31.12% |
| Cash Return on Invested Capital | -53.68% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 2.82 |
| Daily high | 2.94 |
| Daily low | 2.82 |
| Daily Volume | 5K |
| All-time high | 3330.00 |
| 1y analyst estimate | 26.00 |
| Beta | 0.58 |
| EPS (TTM) | -1.98 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BLRX | S&P500 | |
| Current price drop from All-time high | -99.92% | -1.82% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 29 Jan 2025 | 9 Mar 2009 |
| Avg drop from high | -82.73% | -10.84% |
| Avg time to new high | 903 days | 12 days |
| Max time to new high | 3538 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
12.36M
Marketcap category
Small-cap
Description
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Employees
28
Website
Investor relations
-
SEC filings
CEO
Philip Adam Serlin
Country
USA
City
Modi'in
Stock type
American depositary share
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page